Ethics Lecture in Denmark | How IRBs can do better

Vinay Prasad, MD MPH; Physician & Professor
Hematologist/ Oncologist
Professor of Epidemiology, Biostatistics and Medicine
Author of 450+ Peer Reviewed papers, 2 Books, 2 Podcasts, 100+ op-eds.

Follow me on:
Twitter @vprasadmdmph

[hjong]

The medical organization needs a doctor like Dr. Prasad to be on the ethics committee.

[jevandezande]

"Doctors, we're trained in lots of things, but understanding trials, I don't think so. I think that somebody with a Bachelor's degree who's motivated can outperform most doctors any day of the week."

[blabberblabbing]

Brillant.
I've watched/read most of your recent content and though I usually thoroughly appreciate it, this lecture is FANTASTIC. Especially the final Q&A (min > 30:00).

Hopefully some researchers will follow your footsteps and start publish content to really make some (institutional & commercial) giants crumble.

[sralph]

One thing is for sure, doctors, pharma, FDA, CDC: It is not for patients, it is all about profit.

[sallyjones]

I am so disappointed in the clinical trial industry. If you’ve got enough money, you can buy the results you want

[olibertosoto]

How can IRBs do better? Honest accountability and consequences - oldest concep in the world. We're all aware that this is a growing problem not just in medicine - it's in our face obvious, even normal at this point.

[michaelbradley]

That microphone system does not pick up questions from the audience, so in future lectures that you plan to upload to YT, could you please repeat the question asked or at least the relevant part of the question asked.

[toddrf]

As a result of listening to many of Dr. Prasad’s talks, when I hear that a new medical study showed “X”, I no longer take that announcement at face value.

[JCResDoc]

*warmer audience this one.* lovely presentation. i feel a lil less corrupt every time. _JC

[JCResDoc]

*21:00** why would thr ever be no post mkt commitment. why. it is insane.* in fact, get companies out of it: wtaf is the point of the EMR if we arent using it for some kind of active follow up on all interventions? (apart form increasing physician suicidal ideation.) _JC

[JCResDoc]

32:44 who is hapy w good medicine (decision point problem) _JC

[JCResDoc]

*14:00** OS v pfs:* no benefit at 18m, QoL = (slide)
_JC

[JCResDoc]

*35:50** random speed paradox* randomization actually being faster, in short order (if your drug works) _JC

[ImNoclue]

How can they claim these patients gave informed consent to this trial?